The miR-34 family in cancer and apoptosis

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• The p53 tumor suppressor gene regulates microRNA (miRNA) expression.
• miR-34a and miR-34b/c are direct p53 target genes, with ectopic expression inducing apoptosis, cell-cycle arrest, or senescence.
• CpG methylation inactivates miR-34a/b/c gene promoters in various tumors, and miR-34a deletions are common in neuroblastomas.

Purpose of the Study:

• To review the evidence for miR-34a and miR-34b/c's role in the apoptotic response of normal and tumor cells.
• To highlight the significance of miR-34 in p53-mediated tumor suppression.
• To discuss the implications of miR-34 dysregulation in cancer and chemotherapy resistance.

Main Methods:

• Literature review of studies investigating p53-miRNA interactions.
• Analysis of data on miR-34a/b/c expression in normal and cancerous tissues.
• Examination of the functional consequences of miR-34a/b/c dysregulation in apoptosis and cell cycle control.

Main Results:

• p53 directly induces miR-34a and miR-34b/c expression.
• miR-34a and miR-34b/c promote apoptosis and cell-cycle arrest.
• Inactivation of miR-34a/b/c by promoter methylation or deletion is observed in various cancers, including neuroblastoma.
• Loss of miR-34 expression correlates with resistance to p53-activating chemotherapy agents.

Conclusions:

• miR-34a and miR-34b/c are critical mediators of p53's tumor-suppressive functions, primarily through the induction of apoptosis.
• Dysregulation of miR-34a/b/c contributes to tumorigenesis and can confer resistance to cancer therapy.
• Restoring miR-34 expression may represent a therapeutic strategy for certain cancers.